|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| C07K 16/46 | |||
| A61K 39/395 | |||
| A61P 31/12 | |||
| A61P 35/00 | |||
| A61P 37/00 |
| (11) | Number of the document | 2426150 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11186901.2 |
| Date of filing the European patent application | 2007-06-28 | |
| (97) | Date of publication of the European application | 2012-03-07 |
| (45) | Date of publication and mention of the grant of the patent | 2017-10-25 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 06116429 | 2006-06-30 | EP |
| (72) |
Spee, Pieter, DK
Padkjęr, S ren Berg, DK
|
| (73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
| (54) | ANTI-NKG2A ANTIBODIES AND USES THEREOF |
| ANTI-NKG2A ANTIBODIES AND USES THEREOF |